Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas
1997

Enzyme Activity in Lung, Colon, and Liver Carcinomas

Sample size: 30 publication 15 minutes Evidence: moderate

Author Information

Author(s): N Durany, J Joseph, E Campo, R Molina, J Carreras

Primary Institution: University of Barcelona

Hypothesis

The study aims to compare the levels of phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, and enolase activities in normal and cancerous tissues.

Conclusion

All tumors showed higher phosphoglycerate mutase and enolase activities but lower 2,3-bisphosphoglycerate phosphatase activity compared to normal tissues.

Supporting Evidence

  • All tumors presented higher phosphoglycerate mutase and enolase activities than normal tissues.
  • Normal tissues contained mainly type BB isoenzyme of phosphoglycerate mutase.
  • Enolase isoenzymes showed varying proportions in normal and tumor tissues.

Takeaway

The study found that cancer tissues have more of certain enzymes than normal tissues, which might help us understand how cancer cells behave.

Methodology

The study involved comparing enzyme activities and isoenzyme distributions in normal and tumor tissues using various biochemical assays.

Limitations

The study does not provide data on the long-term implications of enzyme activity changes in cancer progression.

Participant Demographics

The study included samples from patients with lung adenocarcinoma, squamous cell carcinoma, carcinoid tumors, colon adenocarcinoma, and liver adenocarcinoma.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication